Study of SYH2062 Injection in Healthy Chinese Volunteers

Phase 1 Recruiting 46 enrolled CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the safety, tolerability, efficacy, pharmacodynamics and pharmacokinetics of SYH2062 injection in healthy Chinese volunteers

Timeline

Start: 2025-03-01
Primary completion: 2025-12-31
Completion: 2025-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SYH2062	Unknown	—	Subcutaneous

Indications

No indication recorded.